Tagged with:

Browse by tag


Turning the tide on antibiotic resistance

Picture a world where people routinely die from minor infections, where invasive surgery like organ transplants can’t be performed because it’s too risky, and where hospital wards are breeding grounds for disease.


GSK’s Chief Immunology Officer discusses unlocking the secrets of the immune system to tackle disease

As science evolves we are learning that the immune system does so much more than protect us from an outside attack.

How we do business

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.


Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.


Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Access to healthcare

The fight against malaria

By the time the second hand on your watch has circled its dial, a child will have died of malaria.

How we do business

The hope for a cure for HIV/AIDS in our lifetime

In the past three decades, we’ve made advances in treatments for HIV/AIDS but a cure has remained elusive.


Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?


Data transparency

We have a long-standing commitment to data transparency.

Our people

Why I fight malaria: Laura's story

Laura is a scientist and a mom. Here she describes what motivates her to fight against malaria.


Inside the open lab

"The biggest surprise for me was the openness,” says Thulasi Warrier. “I thought I would be put in a cubicle and not encouraged to speak.”

Our people

On the job with GSK's medical device research team

A mechanical engineering graduate on a GSK Future Leaders Programme is helping to develop user-friendly devices to administer treatments safely.


The race to richer data in clinical trials

That’s why we’re working with a range of partners, including the McLaren Technology Group and Medidata, to find new ways to use biosensors and mobile health platforms to improve patient care.


Cell and gene therapy: a new era of medicine

Since the structure of DNA was discovered by James Watson and Francis Crick in 1953, significant advances have been made in our understanding of diseases caused by faulty genes.


On target for a new era of drug discovery?

Almost half a century ago, the world entered an apparent golden era of drug discovery. Driven by a rapidly advancing understanding of biological processes in the body and medicinal chemistry, a generation of game-changing new medicines emerged.


Take a deep breath - your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity


Welcome to the golden age of vaccine innovation

With vaccines widely available for many of the most common childhood illnesses, like measles and mumps, many people think that the golden age of vaccine development has passed. Our head of Vaccines R&D, Dr Emmanuel Hanon, thinks they’re wrong.

Our people

The journey from research to respiratory treatment

Meet Elaine Jones. She heads up a team that follows each step of a respiratory medicine’s journey from research to becoming a treatment.

Back to top